704 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ABBV AbbVie Inc. $95.37 $144.42B N/A
Article Searches
Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs http://www.zacks.com/stock/news/415516/pharma-stock-roundup-fda-okays-line-extensions-of-lly-pfe-abbv-cancer-drugs?cid=CS-ZC-FT-415516 May 17, 2019 - FDA grants approval for line extensions of Lilly (LLY), Pfizer (PFE) and Roche (RHHBY)/AbbVie's (ABBV) cancer drugs
Why AbbVie (ABBV) is a Great Dividend Stock Right Now http://www.zacks.com/stock/news/414365/why-abbvie-abbv-is-a-great-dividend-stock-right-now?cid=CS-ZC-FT-414365 May 15, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
Top Ranked Income Stocks to Buy for May 8th http://www.zacks.com/commentary/410876/top-ranked-income-stocks-to-buy-for-may-8th?cid=CS-ZC-FT-410876 May 08, 2019 - Top Ranked Income Stocks to Buy for May 8th
3 Top Dividend Stocks to Buy Now https://www.fool.com/investing/2019/05/07/3-top-dividend-stocks-to-buy-now.aspx?source=iedfolrf0000001 May 07, 2019 - Give these under-the-radar companies a closer look.
The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo http://www.zacks.com/stock/news/409269/the-zacks-analyst-blog-highlights-merck-pfizer-abbvie-sanofi-and-glaxo?cid=CS-ZC-FT-409269 May 06, 2019 - The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo
Top Ranked Income Stocks to Buy for May 6th http://www.zacks.com/commentary/409187/top-ranked-income-stocks-to-buy-for-may-6th?cid=CS-ZC-FT-409187 May 06, 2019 - Top Ranked Income Stocks to Buy for May 6th
Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod http://www.zacks.com/stock/news/408311/pharma-stock-roundup-mrk-lly-pfe-report-q1-earnings-sny-abbv-drugs-get-eu-nod?cid=CS-ZC-FT-408311 May 03, 2019 - Merck (MRK), Pfizer (PFE), Lilly (LLY) announce Q1 results. European Commission grants approval to AbbVie's (ABBV) Skyrizi and Sanofi's (SNY) Zynquista.
The Zacks Analyst Blog Highlights: Facebook, Comcast, AbbVie, Union Pacific and Air Products http://www.zacks.com/stock/news/406434/the-zacks-analyst-blog-highlights-facebook-comcast-abbvie-union-pacific-and-air-products?cid=CS-ZC-FT-406434 May 01, 2019 - The Zacks Analyst Blog Highlights: Facebook, Comcast, AbbVie, Union Pacific and Air Products
Top Stock Reports for Facebook, Comcast & AbbVie http://www.zacks.com/research-daily/405663/top-stock-reports-for-facebook-comcast-abbvie?cid=CS-ZC-FT-405663 Apr 30, 2019 - Top Stock Reports for Facebook, Comcast & AbbVie
Better Big Pharma Stock: AbbVie vs. AstraZeneca https://www.fool.com/investing/2019/04/29/better-big-pharma-stock-abbvie-vs-astrazeneca.aspx?source=iedfolrf0000001 Apr 29, 2019 - These A-list drugmakers must both contend with expiring patents, new drug uncertainties, and hungry competitors. But they're in different stages of their cyclical journeys.

Pages: 12345678...71

<<<Page 3>